Brief: Molecular Templates Says Bristol Myers Squibb Terminates Research Collaboration With Co

Molecular Templates

15/03/2024 21:52

March 15 (Reuters) - Bristol-Myers Squibb Co  BMY.N :
    * MOLECULAR TEMPLATES -  BRISTOL MYERS SQUIBB NOTIFIED CO ON
MARCH
13 IT DOES NOT INTEND TO CONTINUE RESEARCH COLLABORATION IT
ENTERED INTO WITH COMPANY
    * MOLECULAR TEMPLATES INC -  BMS WOULD BE TERMINATING
COLLABORATION AGREEMENT IN ITS ENTIRETY
    * MOLECULAR TEMPLATES - TERMINATION WILL BE EFFECTIVE ON
JUNE 13,
2024, OR 90 DAYS FOLLOWING COMPANY'S RECEIPT OF BMS'S WRITTEN
NOTICE OF TERMINATION
    * MOLECULAR TEMPLATES - WILL REDUCE COSTS ASSOCIATED WITH
COLLABORATION AGREEMENT, FOCUS RESOURCES EXCLUSIVELY ON
WHOLLY-OWNED CLINICAL-STAGE PROGRAMS

Source text for Eikon:  ID:n0001193125-24-069133 
Further company coverage:  BMY.N 

 ((Reuters.Briefs@thomsonreuters.com;))